These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 9317076
21. Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection. Attallah AM, Shiha GE, Ismail H, Mansy SE, El-Sherbiny R, El-Dosoky I. Clin Biochem; 2009 Apr; 42(6):455-61. PubMed ID: 19063876 [Abstract] [Full Text] [Related]
28. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis. Genesca J, Gonzalez A, Segura R, Catalan R, Marti R, Varela E, Cadelina G, Martinez M, Lopez-Talavera JC, Esteban R, Groszmann RJ, Guardia J. Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750 [Abstract] [Full Text] [Related]
29. Simultaneous measurements of serum alpha-fetoprotein and protein induced by vitamin K absence for detecting hepatocellular carcinoma. South Tohoku District Study Group. Ishii M, Gama H, Chida N, Ueno Y, Shinzawa H, Takagi T, Toyota T, Takahashi T, Kasukawa R. Am J Gastroenterol; 2000 Apr; 95(4):1036-40. PubMed ID: 10763956 [Abstract] [Full Text] [Related]
32. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma. Soresi M, Magliarisi C, Campagna P, Leto G, Bonfissuto G, Riili A, Carroccio A, Sesti R, Tripi S, Montalto G. Anticancer Res; 2003 Apr; 23(2C):1747-53. PubMed ID: 12820452 [Abstract] [Full Text] [Related]
34. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis. Stroffolini T, Almasio PL, Persico M, Bollani S, Benvegnù L, Di Costanzo G, Pastore G, Aghemo A, Stornaiuolo G, Mangia A, Andreone P, Stanzione M, Mazzella G, Saracco G, Del Poggio P, Bruno S, Italian Association of the Study of the Liver Disease (AISF). Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087 [Abstract] [Full Text] [Related]
35. Distribution of the heterogeneity of des-gamma-carboxyprothrombin in patients with hepatocellular carcinoma. Uehara S, Gotoh K, Handa H, Tomita H, Senshuu M. J Gastroenterol Hepatol; 2005 Oct; 20(10):1545-52. PubMed ID: 16174072 [Abstract] [Full Text] [Related]
36. Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients. Genesca J, Segura R, Gonzalez A, Catalan R, Marti R, Torregrosa M, Cereto F, Martinez M, Esteban R, Guardia J. Am J Gastroenterol; 2000 Jun; 95(6):1539-44. PubMed ID: 10894593 [Abstract] [Full Text] [Related]
37. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Beneduce L, Castaldi F, Marino M, Quarta S, Ruvoletto M, Benvegnù L, Calabrese F, Gatta A, Pontisso P, Fassina G. Cancer; 2005 Jun 15; 103(12):2558-65. PubMed ID: 15887222 [Abstract] [Full Text] [Related]
38. [Clinical usefulness of plasma activities of gelatinase (matrix metalloproteinase-2 and 9) in chronic liver disease]. Kwon OS, Lim DY, Kwon KA, Chung MG, Park DK, Kim SS, Kim YS, Kwon SY, Koo YS, Kim YK, Choi DJ, Kim JH, Hwang YJ, Byun KS, Lee CH. Taehan Kan Hakhoe Chi; 2003 Sep 15; 9(3):222-30. PubMed ID: 14515040 [Abstract] [Full Text] [Related]
39. Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma. Moussa YI, Plevris JN, Hayes PC. Eur J Gastroenterol Hepatol; 2000 Feb 15; 12(2):159-63. PubMed ID: 10741929 [Abstract] [Full Text] [Related]
40. Nitrite and nitrate measurement by Griess reagent in human plasma: evaluation of interferences and standardization. Giustarini D, Rossi R, Milzani A, Dalle-Donne I. Methods Enzymol; 2008 Feb 15; 440():361-80. PubMed ID: 18423230 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]